Medical Countermeasures

• CORE SERVICES

  BARDA supports a number of core services to assist the production of required products, in a manner that is timely, reliable and cost effective.

• CBRN PROGRAMS

  The Pandemic and All Hazards Preparedness Act (PAHPA) established BARDA as the focal point within HHS for the advanced development and acquisition of medical countermeasures to protect the American civilian population against CBRN and naturally occurring threats to public health.

• PANDEMIC INFLUENZA

  BARDA uses a comprehensive portfolio approach to develop and acquire a broad array of medical countermeasures for pandemic flu, including vaccines, therapeutics, diagnostics, and non-pharmaceutical countermeasures and to build and sustain their domestic manufacturing infrastructure.

• INNOVATION

  BARDA's Strategic Science and Technology Division helps bring innovation to our programs. The innovation programs identify and support the advancement of platform technologies that enhance capabilities for the development and manufacturing of medical countermeasures that focus on biodefense, pandemic influenza and other emerging infectious diseases.

• STOCKPILE BUILDING

  Congress seeks to improve our Nation's emergency preparedness with Project BioShield, which provides the government with the ability to develop, acquire, stockpile, and make available the medical countermeasures needed to protect the U.S. population against a public health threat.

BARDA funding and acquisitions bridge the "valley of death" characterizing the late stages of product development. BARDA's support ensures continuity of funding for medical countermeasures developed by industry or emerging from the basic research and preclinical development activities sponsored by the National Institutes of Health (NIH). In procuring medical countermeasures for the Strategic National Stockpile, BARDA enhances the capabilities of the Centers for Disease Control and Prevention (CDC) to organize an effective response.

BARDA manages Project BioShield, which includes the procurement and advanced development of medical countermeasures for chemical, biological, radiological, and nuclear agents, as well as the advanced development and procurement of medical countermeasures for pandemic influenza and other emerging infectious diseases that fall outside the auspices of Project BioShield. In addition, BARDA manages the Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) and is a key partner in implementing the PHEMCE strategies.

To learn more about requirements setting for medical countermeasure research and development click here.

Newsroom

Publications

PHEMCE Strategy and Implementation Plan 2016

Considering the progress achieved and the remaining strategic gaps in MCM preparedness, the PHEMCE annually examines the SIP goals and objectives and re-adjusts or adds to them, as needed...

PHEMCE Strategy and Implementation Plan 2015

The goal of the 2016 PHEMCE Stakeholders Workshop was to provide a forum within which a broad spectrum of stakeholders in the PHEMCE mission of effective provision of emergency medical countermeasures could learn about PHEMCE activities, interact, and provide input to PHEMCE partners about their interests, issues, concerns, and priorities...

BARDA Project Listing

View maps and project details for BARDA projects with work performed inside and outside of the United States.

Popular Resources

Industry partners are encouraged to visit the BARDA Broad Agency Announcement and sign up for a BARDA TechWatch meeting.